Humoral factors in the pathogenesis of Graves' disease.

PubWeight™: 1.98‹?› | Rank: Top 2%

🔗 View Article (PMID 4865519)

Published in Physiol Rev on January 01, 1968

Authors

J M McKenzie

Articles citing this

The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc (1994) 2.23

A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes. Biochem J (1975) 1.24

The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc Natl Acad Sci U S A (1972) 1.03

Endocrine exophthalmos. Br Med J (1972) 0.92

Graves' ophthalmopathy. Can Med Assoc J (1981) 0.91

Ocular manifestations of Graves' disease: a review. J R Soc Med (1984) 0.88

Long-term follow-up of ophthalmic Graves' disease. CMAJ (1987) 0.87

Peripheral blood B-lymphocyte abnormalities associated with hyperthyroidism of Graves' disease. Clin Exp Immunol (1976) 0.81

Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis. Immunology (1969) 0.81

Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity. Thyroid Res (2012) 0.77

Aetiology of hyperthyroidism. II. Br Med J (1974) 0.77

LATS and the Thyroid Gland. Calif Med (1968) 0.75

Inhibition of the thyroid-stimulating globulin (LATS) by particulate and soluble cell fractions. Proc R Soc Med (1968) 0.75

[Current status of diagnosis in thyroid diseases]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1972) 0.75

Treatment of thyrotoxicosis. Calif Med (1970) 0.75

Failure to detect long-acting thyroid stimulator with the immunofluorescence technique. Clin Exp Immunol (1970) 0.75

Dysthyroid ophthalmopathy: an update. J Natl Med Assoc (1979) 0.75

Thyroid physiology. Br Med J (1972) 0.75

Editorial: hyperthyroidism and Grave's disease. Br Med J (1975) 0.75

Articles by these authors

(truncated to the top 100)

The dietary intake of children with IDDM. Diabetes Care (1996) 1.67

Complex segregation analysis of antibodies to thyroid peroxidase in Old Order Amish families. Am J Med Genet (1993) 1.46

Selenium deficiency in total parenteral nutrition. Am J Clin Nutr (1979) 1.43

Growth of hypercholesterolemic children completing physician-initiated low-fat dietary intervention. J Pediatr (1998) 1.40

A thyroid-stimulating life: an interview with Dr. J. Maxwell McKenzie. Thyroid (2001) 1.39

Inhalational induction with sevoflurane in an adult with severe complex central airways obstruction. Anaesth Intensive Care (1997) 1.39

Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab (1983) 1.33

Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2001) 1.30

Graves' disease without hyperthyroidism. Am J Med (1965) 1.14

Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab (1986) 1.13

Bulimia comorbidity in the general population and in the clinic. Psychol Med (1994) 1.12

Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative). Metabolism (1972) 1.09

Zinc deficiency during the latter third of pregnancy: effects on fetal rat brain, liver, and placenta. J Nutr (1975) 1.05

A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. J Clin Endocrinol Metab (1976) 1.05

Humoral immunity in Graves' disease. Clin Endocrinol Metab (1978) 1.01

Alteration of the zinc anc copper concentration of hair. Am J Clin Nutr (1978) 1.01

GABA(B) receptors mediate motility signals for migrating embryonic cortical cells. Cereb Cortex (2001) 0.99

Experience with the bio-assay of the long-acting thyroid stimulator. J Clin Endocrinol Metab (1966) 0.99

Ultra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry). Neth Heart J (2015) 0.99

Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease. J Clin Endocrinol Metab (1968) 0.98

Prolonged extracorporeal circulation without heparin. Evaluation of the Medtronic Minimax oxygenator. ASAIO J (1993) 0.95

Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann Intern Med (1980) 0.95

Urinary excretion of cadmium, zinc and copper in normotensive and hypertensive women. N Z Med J (1973) 0.94

Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest (1983) 0.94

Thyroid hydrolysis of cyclic AMP as influenced by thyroid gland activity. Biochim Biophys Acta (1971) 0.93

Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells. Endocrinology (1986) 0.92

Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol (1994) 0.91

Hyperpolarization of thyroid cells in vitro by thyrotropin and cyclic AMP. Am J Physiol (1976) 0.90

Comparison of the effects of thyrotropin and the long-acting thyroid stimulator on guinea pig adipose tissue. Endocrinology (1971) 0.90

The spectrum and significance of autoantibodies reacting with the thyrotropin receptor. Endocrinol Metab Clin North Am (1987) 0.89

Interaction of thyrotropin or the long-acting thyroid stimulator with theophylline. Endocrinology (1968) 0.89

Pathogenesis of neonatal Graves' disease. J Endocrinol Invest (1978) 0.89

Circulatory and ventilatory response to exercise in thyrotoxicosis. N Engl J Med (1967) 0.89

A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. Acta Psychiatr Scand (2003) 0.89

Solubilization, purification, and partial characterization of thyrotropin receptor from bovine and human thyroid glands. Endocrinology (1982) 0.88

Hypothyroidism-induced changes in triiodothyronine binding to nuclei and cytosol-binding proteins in rat liver. Endocrinology (1978) 0.88

Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone or prolactin. A case report. Ann Intern Med (1978) 0.87

Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry (2010) 0.87

Immune reactions in patients with Graves' disease. Am J Med (1978) 0.87

Measures of temperament and character are differentially impacted on by depression severity. J Affect Disord (2010) 0.87

Content of zinc in serum, urine, hair, and toenails of New Zealand adults. Am J Clin Nutr (1979) 0.86

Pituitary hyperthyroidism. Case report and review of the literature. Am J Med (1978) 0.86

Thyroid-stimulating antibody (TSAb) of Graves' disease. Life Sci (1983) 0.86

Conservative treatment of de Quervain's disease. Br Med J (1972) 0.86

Stress and the immune response in rats. Int Arch Allergy Appl Immunol (1976) 0.85

Visualization of the thyrotropin receptor on the cell surface by potent autoantibodies. J Clin Endocrinol Metab (1994) 0.85

Influences of cholera toxin on thyroid stimulation by thyrotropin and thyroid-stimulating antibody. Endocrinology (1980) 0.85

Zoological specificity of human thyroid-stimulating antibody. J Clin Endocrinol Metab (1978) 0.85

The long-acting thyroid stimulator: its role in Graves' disease. Recent Prog Horm Res (1967) 0.85

Cyclic AMP: a mediator of thyroid stimulation by thyrotropin. Am J Physiol (1967) 0.85

The gamma globulin of Graves' disease: thyroid stimulation by fraction and fragment. Trans Assoc Am Physicians (1965) 0.84

Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. J Clin Invest (1987) 0.83

LATS in Graves' disease. Recent Prog Horm Res (1976) 0.83

Release of thyrotropin by the rat pituitary gland in vitro. Endocrinology (1966) 0.82

Supporting role of the adrenal cortex in the induction of hyperfibrinogenemia. Am J Physiol (1968) 0.82

Selenium supplementation in total parenteral nutrition. JPEN J Parenter Enteral Nutr (1981) 0.82

Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic "fingerprints". J Clin Endocrinol Metab (1999) 0.82

Studies of homologous immunization with mouse harderian gland. Metabolism (1971) 0.82

Effects of gamma-interferon and tumor necrosis factor alpha on thyroid cells: induction of class II antigen and inhibition of growth stimulation. Mol Cell Endocrinol (1988) 0.81

Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells. J Clin Invest (1988) 0.81

Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease. J Clin Invest (1985) 0.81

Isoelectric focusing of thyroid-stimulating antibody of Graves' disease. Endocrinology (1978) 0.81

The influence of thyrotropin on harderian gland glycosaminoglycans of the mouse. Proc Soc Exp Biol Med (1970) 0.81

Effect of thyrotropin and of LATS on mouse thyroid cyclic AMP. Metabolism (1973) 0.80

Cadmium in blood and urine among smokers and non-smokers with high cadmium intake via food. Toxicology (1983) 0.80

Influence of cholera toxin on in vitro refractoriness to thyrotropin of thyroids from rats fed propylthiouracil. Endocrinology (1980) 0.80

Circulating immune complexes in Graves' disease. Endocr Res Commun (1976) 0.80

Zinc deficiency and brain development in the rat. Fed Proc (1975) 0.80

Interpersonal psychotherapy for anorexia nervosa. Int J Eat Disord (2000) 0.79

Relationship of long-acting thyroid stimulator to pretibial myxedema. Arch Dermatol (1970) 0.79

Experimental production of a thyroid-stimulating antithyroid antibody. J Clin Endocrinol Metab (1968) 0.79

Graves' disease. Med Clin North Am (1975) 0.79

Report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease. Rheumatol Rehabil (1981) 0.79

Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor. J Clin Endocrinol Metab (1990) 0.79

Do thyroid growth-promoting immunoglobulins exist? J Clin Endocrinol Metab (1990) 0.79

Lack of iodide effect on serum and pituitary thyrotropin in vivo. Endocrinology (1967) 0.79

Stimulation by thyrotropin, long-acting thyroid stimulator, and dibutyryl 3',5'-adenosine monophosphate of protein and ribonucleic acid synthesis and ribonucleic acid polymerase activities in porcine thyroid in vitro. Biochemistry (1971) 0.79

Thyroglobulin in fractions of thyroid homogenate. Endocrinology (1970) 0.79

Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue. J Clin Endocrinol Metab (1978) 0.78

Assays of thyroid-stimulating antibody. Methods Enzymol (1985) 0.78

Evaluation of the hazards of sickle trait in aviation. Aviat Space Environ Med (1977) 0.78

Regulation of the rat thyrotropin receptor in vitro. Endocrinology (1981) 0.78

The role of TRH in the neoteny of the Mexican axolotl (Ambystoma mexicanum). Gen Comp Endocrinol (1974) 0.78

Metabolic balance of zinc, copper, cadmium, iron, molybdenum and selenium in young New Zealand women. Br J Nutr (1973) 0.78

Analysis of submicrogramme levels of cadmium in whole blood, urine and hair by graphite furnace atomic absorption spectroscopy. J Anal Toxicol (1982) 0.78

Elevated phosphorylated tau pT-181 in a possible PRNP codon 129 MV vCJD case. J Neurol Neurosurg Psychiatry (2010) 0.78

One-year follow-up of nutrition education for hypercholesterolemic children. Am J Public Health (1998) 0.78

Infections at the site of a hip implant. Successful and unsuccessful management. Clin Orthop Relat Res (1991) 0.78

Influence of cytokines on growth and differentiated function of FRTL5 cells. Endocrinology (1989) 0.77

Hormonal relase by dispersed pituitary cells. Can J Physiol Pharmacol (1972) 0.77

Tissue concentration of cadmium, zinc and copper from autopsy samples. N Z Med J (1974) 0.77

Thyrotropin binding to rat thyroid membranes: reduced capacity associated with goitrogenesis. Endocrinology (1980) 0.77

The site of the molecular defect in the thyroid gland of the hyt/hyt mouse: abnormalities in the TSH receptor-G protein complex. Thyroid (1991) 0.77

Evaluation of the biological significance of leukocyte infiltration of the thyroid in Graves' disease. Int Arch Allergy Immunol (1992) 0.77

Changes in thyroid ribonucleic acid, ribonucleases and alkaline ribonuclease inhibitor. Endocrinology (1974) 0.77

pH-dependent lysis of canine erythrocytes. J Appl Physiol (1967) 0.77

Effects of thyrotropin on 35S-sulfate uptake by mouse Harderian gland. Endocrinology (1969) 0.76

Clinical, biochemical, and radiologic reversibility of hyperprolactinemic galactorrhea-amenorrhea and abnormal sella by thyroxine in a patient with primary hypothyroidism. Am J Obstet Gynecol (1978) 0.76

An initial report on a double-blind trial comparing small and large doses of gold in the treatment of rheumatoid disease. Rheumatol Rehabil (1977) 0.76

Increased total thyroxine with normal free thyroxine in antithyroid antiserum. Endocrinology (1967) 0.76